تری فلوپرازین (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "تری فلوپرازین" in Persian language version.

refsWebsite

Global rank Persian rank

4^th place

5^th place

2^nd place

2^nd place

399^th place

104^th place

1web.archive.org

1^st place

1^st place

1aspetjournals.org

6,663^rd place

4,237^th place

18^th place

50^th place

14^th place

29^th place

1psychiatryonline.org

4,032^nd place

2,052^nd place

1books.google.com

3^rd place

6^th place

archive.today

Creese I, Burt DR, Snyder SH (1996). "Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs". The Journal of Neuropsychiatry and Clinical Neurosciences. 8 (2): 223–6. doi:10.1176/jnp.8.2.223. PMID 9081563. Archived from the original on 27 July 2011. Retrieved 2009-06-21.

aspetjournals.org

molpharm.aspetjournals.org

Huerta-Bahena J, Villalobos-Molina R, García-Sáinz JA (January 1983). "Trifluoperazine and chlorpromazine antagonize alpha 1- but not alpha2- adrenergic effects". Molecular Pharmacology. 23 (1): 67–70. PMID 6135146. Archived from the original on 29 August 2021. Retrieved 2009-06-21.

books.google.com

Ebadi, Manuchair S (1998). "Trifluoperazine Hydrochloride". CRC desk reference of clinical pharmacology (illustrated ed.). CRC Press. ISBN 978-0-8493-9683-0. Retrieved 2009-06-21.

doi.org

Seeman P, Lee T, Chau-Wong M, Wong K (June 1976). "Antipsychotic drug doses and neuroleptic/dopamine receptors". Nature. 261 (5562): 717–9. Bibcode:1976Natur.261..717S. doi:10.1038/261717a0. PMID 945467.
Creese I, Burt DR, Snyder SH (1996). "Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs". The Journal of Neuropsychiatry and Clinical Neurosciences. 8 (2): 223–6. doi:10.1176/jnp.8.2.223. PMID 9081563. Archived from the original on 27 July 2011. Retrieved 2009-06-21.

drugs.com

"Trifluoperazine Hydrochloride". The American Society of Health-System Pharmacists. Retrieved 8 January 2017.

harvard.edu

ui.adsabs.harvard.edu

Seeman P, Lee T, Chau-Wong M, Wong K (June 1976). "Antipsychotic drug doses and neuroleptic/dopamine receptors". Nature. 261 (5562): 717–9. Bibcode:1976Natur.261..717S. doi:10.1038/261717a0. PMID 945467.

nih.gov

pubmed.ncbi.nlm.nih.gov

Huerta-Bahena J, Villalobos-Molina R, García-Sáinz JA (January 1983). "Trifluoperazine and chlorpromazine antagonize alpha 1- but not alpha2- adrenergic effects". Molecular Pharmacology. 23 (1): 67–70. PMID 6135146. Archived from the original on 29 August 2021. Retrieved 2009-06-21.
Seeman P, Lee T, Chau-Wong M, Wong K (June 1976). "Antipsychotic drug doses and neuroleptic/dopamine receptors". Nature. 261 (5562): 717–9. Bibcode:1976Natur.261..717S. doi:10.1038/261717a0. PMID 945467.
Creese I, Burt DR, Snyder SH (1996). "Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs". The Journal of Neuropsychiatry and Clinical Neurosciences. 8 (2): 223–6. doi:10.1176/jnp.8.2.223. PMID 9081563. Archived from the original on 27 July 2011. Retrieved 2009-06-21.

psychiatryonline.org

neuro.psychiatryonline.org

Creese I, Burt DR, Snyder SH (1996). "Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs". The Journal of Neuropsychiatry and Clinical Neurosciences. 8 (2): 223–6. doi:10.1176/jnp.8.2.223. PMID 9081563. Archived from the original on 27 July 2011. Retrieved 2009-06-21.

web.archive.org

Huerta-Bahena J, Villalobos-Molina R, García-Sáinz JA (January 1983). "Trifluoperazine and chlorpromazine antagonize alpha 1- but not alpha2- adrenergic effects". Molecular Pharmacology. 23 (1): 67–70. PMID 6135146. Archived from the original on 29 August 2021. Retrieved 2009-06-21.